Chromoblastomycosis in Southern Madagascar: Our Experience

The authors present their experience in the detection, clinical diagnosis, treatment and outcomes of 20 subjects affected by chromoblastomycosis identified in two regions of Southern Madagascar over a long period (1990–2025). Mucocutaneous manifestations proved difficult to resolve therapeutically, not only in relation to the drugs used and the duration of treatment, but also because of patient compliance and the numerous logistical problems present in these regions. The proportion of clinically cured subjects was 30%, and this included only those with mild to moderate forms. The most frequently used drug was terbinafine.